Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
FG Dhermain, P Hau, H Lanfermann… - The Lancet …, 2010 - thelancet.com
Imaging techniques are important for accurate diagnosis and follow-up of patients with
gliomas. T1-weighted MRI, with or without gadolinium, is the gold standard method …
gliomas. T1-weighted MRI, with or without gadolinium, is the gold standard method …
MRI in treatment of adult gliomas
JW Henson, P Gaviani, RG Gonzalez - The lancet oncology, 2005 - thelancet.com
Diffuse astrocytomas of the adult cerebral hemispheres are unique among tumours in
human beings in the extent to which their imaging features are related to histopathological …
human beings in the extent to which their imaging features are related to histopathological …
Advanced MRI techniques in the monitoring of treatment of gliomas
Opinion statement With advances in treatments and survival of patients with glioblastoma
(GBM), it has become apparent that conventional imaging sequences have significant …
(GBM), it has become apparent that conventional imaging sequences have significant …
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group
Summary Response Assessment in Neuro-Oncology (RANO) response criteria have been
established and were updated in 2023 for MRI-based response evaluation of diffuse …
established and were updated in 2023 for MRI-based response evaluation of diffuse …
Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI
The assessment of treatment response in glioblastoma is difficult with MRI because reactive
blood–brain barrier alterations with contrast enhancement can mimic tumor progression. In …
blood–brain barrier alterations with contrast enhancement can mimic tumor progression. In …
Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI
N Galldiks, M Rapp, G Stoffels, GR Fink… - European journal of …, 2013 - Springer
Purpose To investigate prospectively the potential of O-(2-[18 F] fluoroethyl)-l-tyrosine (18 F-
FET) PET in comparison to MRI for the assessment of the response of patients with recurrent …
FET) PET in comparison to MRI for the assessment of the response of patients with recurrent …
Advances in neuro-oncology imaging
KJ Langen, N Galldiks, E Hattingen… - Nature Reviews …, 2017 - nature.com
Despite the fact that MRI has evolved to become the standard method for diagnosis and
monitoring of patients with brain tumours, conventional MRI sequences have two key …
monitoring of patients with brain tumours, conventional MRI sequences have two key …
Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine
N Galldiks, V Dunkl, G Ceccon, C Tscherpel… - European journal of …, 2018 - Springer
Background The goal of this prospective study was to compare the value of both
conventional MRI and O-(2-18 F-fluoroethyl)-L-tyrosine (FET) PET for response evaluation in …
conventional MRI and O-(2-18 F-fluoroethyl)-L-tyrosine (FET) PET for response evaluation in …
[HTML][HTML] Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and …
BRJ van Dijken, PJ van Laar, GA Holtman… - European …, 2017 - Springer
Objective Treatment response assessment in high-grade gliomas uses contrast enhanced
T1-weighted MRI, but is unreliable. Novel advanced MRI techniques have been studied, but …
T1-weighted MRI, but is unreliable. Novel advanced MRI techniques have been studied, but …
Metabolic and molecular imaging in neuro-oncology
Techniques for human brain imaging have undergone rapid developments in recent years.
Technological progress has enabled the assessment of many physiological parameters in …
Technological progress has enabled the assessment of many physiological parameters in …
相关搜索
- patients with gliomas pet imaging
- patients with gliomas treatment response
- treatment response pet imaging
- bevacizumab in patients response assessment
- pet in comparison patients with glioblastoma
- treatment response pet in comparison
- treatment response patients with glioblastoma
- glioblastoma patients fet pet